Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland

Open Access

Peer-reviewed

Research Article

Colette Mankowski ,

* E-mail: colette.mankowski@astellas.com

Affiliation Astellas Pharma Europe Ltd., Chertsey, Surrey, United Kingdom
⨯
Sachin Patel,

Affiliation Astellas Pharma UK Ltd, Chertsey, Surrey, United Kingdom
⨯
David Trueman,

Affiliation Abacus International, Bicester, Oxfordshire, United Kingdom
⨯
Anthony Bentley,

Affiliation Abacus International, Bicester, Oxfordshire, United Kingdom
⨯
Chris Poole

Affiliation Astellas Pharma Europe Ltd., Chertsey, Surrey, United Kingdom
⨯

Reader Comments (0)

Pain
Is the Subject Area "Pain" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Cost-effectiveness analysis
Is the Subject Area "Cost-effectiveness analysis" applicable to this article?

Thanks for your feedback.
Neuropathic pain
Is the Subject Area "Neuropathic pain" applicable to this article?

Thanks for your feedback.
Scotland
Is the Subject Area "Scotland" applicable to this article?

Thanks for your feedback.
Nurses
Is the Subject Area "Nurses" applicable to this article?

Thanks for your feedback.
Topical anesthesia
Is the Subject Area "Topical anesthesia" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.